Absence of autoantibodies linked to cancer and autoimmune disorders 26 weeks after BNT162b2 boosting in CoronaVac- primed individuals.

Publication date: Dec 31, 2026

Open Access PDF

Concepts Keywords
26weeks Adult
Cancer Antibodies, Viral
Inactivated Antibodies, Viral
Principal Autoantibodies
Vaccination Autoantibodies
Autoantigens
Autoantigens
Autoimmune Diseases
BNT162 Vaccine
BNT162 Vaccine
COVID-19
COVID-19
COVID-19 Vaccines
COVID-19 Vaccines
Female
Heterologous vaccination
human autoantibodyome
Humans
immune homeostasis
Immunization, Secondary
Immunoglobulin G
Immunoglobulin G
inactivated vaccine
Male
Middle Aged
mRNA vaccine
Neoplasms
proteome-wide profiling
SARS-CoV-2
sinovac COVID-19 vaccine
vaccine safety
Vaccines, Inactivated
Vaccines, Inactivated
Young Adult

Semantics

Type Source Name
disease MESH cancer
disease MESH COVID-19
pathway REACTOME SARS-CoV-2 Infection
disease MESH Autoimmune Diseases

Original Article

(Visited 12 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *